Benjamin F. Edwards & Company’s Repligen RGEN Stock Holding History

Benjamin F. Edwards & Company’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$13K	Hold	101	–	–	﹤0.01%	1654
2024 Q1	$19K	Sell	101 -141	-58%	-$26.9K	﹤0.01%	1551
2023 Q4	$43K	Buy	242 +146	+152%	+$22.7K	﹤0.01%	1289
2023 Q3	$15K	Hold	96	–	–	﹤0.01%	1311
2023 Q2	$14K	Hold	96	–	–	﹤0.01%	1356
2023 Q1	$16K	Hold	96	–	–	﹤0.01%	1321
2022 Q4	$16K	Hold	96	–	–	﹤0.01%	1327
2022 Q3	$18K	Sell	96 -100	-51%	-$21.1K	﹤0.01%	1286
2022 Q2	$32K	Hold	196	–	–	﹤0.01%	1144
2022 Q1	$37K	Hold	196	–	–	﹤0.01%	1101
2021 Q4	$52K	Hold	196	–	–	﹤0.01%	1047
2021 Q3	$57K	Hold	196	–	–	﹤0.01%	995
2021 Q2	$39K	Sell	196 -34	-15%	-$6.6K	﹤0.01%	1082
2021 Q1	$45K	Hold	230	–	–	﹤0.01%	1039
2020 Q4	$44K	Sell	230 -321	-58%	-$58.4K	﹤0.01%	995
2020 Q3	$81K	Buy	551 +321	+140%	+$45.9K	0.01%	794
2020 Q2	$28K	Hold	230	–	–	﹤0.01%	1025
2020 Q1	$22K	Sell	230 -137	-37%	-$13.2K	﹤0.01%	1056
2019 Q4	$34K	Sell	367 -272	-43%	-$22.9K	﹤0.01%	1071
2019 Q3	$49K	Buy	639 +310	+94%	+$27.1K	﹤0.01%	939
2019 Q2	$28K	Hold	329	–	–	﹤0.01%	1087
2019 Q1	$19K	Hold	329	–	–	﹤0.01%	1155
2018 Q4	$17K	Buy	+329	New	+$19.3K	﹤0.01%	1143

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Benjamin F. Edwards & Company's RGEN Position: Q2 2024 in Review

Benjamin F. Edwards & Company held its Repligen (RGEN) position steady in Q2 2024 at 101 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #1654.

Benjamin F. Edwards & Company first reported a position in RGEN in Q4 2018 and has held it in 23 quarters since. The position peaked at $81K in Q3 2020. 455 funds tracked by Wall St. Rank hold RGEN as of Q2 2024.

Benjamin F. Edwards & Company held 101 shares of Repligen worth $13K as of Q2 2024.
Benjamin F. Edwards & Company left its Repligen share count unchanged in Q2 2024.
Repligen made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1654 holding.
Benjamin F. Edwards & Company first reported a position in Repligen in Q4 2018 and has held it in 23 quarters since.
Benjamin F. Edwards & Company's Repligen position peaked at $81K in Q3 2020.
455 funds tracked by Wall St. Rank held Repligen as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.